Overview
Key stats
Fundamentals Sep 10- Open
- $22.38
- 52-wk high
- $34.29
- High
- $23.84
- 52-wk low
- $13.18
- Low
- $22.22
- Prev close
- $22.92
- Mkt cap
- $2.58B
- Volume
- 1.83M
- Fwd P/E
- 1.0x
- Beta
- 0.96
- P/S
- 36.2x
- P/B
- 4.7x
- Profit margin
- +0.0%
- Op margin
- -44461.0%
- ROE
- -65.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Earnings
Earnings came in 8.2% below what analysts expected.
Earnings per share
-$0.97 expected
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $70.6M | $132.0K | $141.0K | $284.0K |
| Cost of what it sold | — | $320.0K | $121.0K | $117.0K |
| Gross profit | $70.6M | -$188.0K | $141.0K | $284.0K |
| What it spent | ||||
| Research and development | $86.3M | $89.2M | $77.6M | $71.6M |
| Sales and admin | $24.3M | $33.7M | $38.7M | $55.0M |
| Total operating expenses | $110.6M | $122.6M | $116.3M | $126.6M |
| What was left | ||||
| Operating profit | -$40.0M | -$122.7M | -$116.2M | -$126.3M |
| Interest on debt | $560.0K | $6.6M | $3.5M | $8.3M |
| Profit before tax | -$34.6M | -$120.4M | -$104.9M | -$127.1M |
| Net profit | -$34.6M | -$120.4M | -$104.9M | -$127.1M |
| EBITDA | -$33.9M | -$114.1M | -$101.3M | -$118.7M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying
Leans bullishSep 3Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Leans bullishSep 3Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Leans bullishSep 3
Macro
21 macro signals shaping VRDN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results